Patents by Inventor Rania Sulaiman

Rania Sulaiman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLUBLE EPOXIDE HYDROLASE AS A TARGET FOR OCULAR DISEASES
    Publication number: 20240082211
    Abstract: Methods of using compounds to inhibit ocular disease are disclosed herein. Methods are disclosed for inhibiting soluble epoxide hydrolase (sEH) for the treatment of ocular diseases, and in particular, retinopathy of prematurity (ROP) or diabetic retinopathy.
    Type: Application
    Filed: November 17, 2023
    Publication date: March 14, 2024
    Inventors: Timothy William Corson, Rania Sulaiman
  • Composition for blocking angiogenesis
    Patent number: 11707445
    Abstract: Compositions including the combination of cremastranone analogs and anti-angiogenic agents and the use of the compositions for targeting ocular angiogenesis such as seen in neovascular eye diseases are disclosed.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: July 25, 2023
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Timothy William Corson, Rania Sulaiman
  • COMPOSITION FOR BLOCKING ANGIOGENESIS
    Publication number: 20210228538
    Abstract: Compositions including the combination of cremastranone analogs and anti-angiogenic agents and the use of the compositions for targeting ocular angiogenesis such as seen in neovascular eye diseases are disclosed.
    Type: Application
    Filed: April 9, 2021
    Publication date: July 29, 2021
    Inventors: Timothy William Corson, Rania Sulaiman
  • SOLUBLE EPOXIDE HYDROLASE AS A TARGET FOR OCULAR DISEASES
    Publication number: 20210228539
    Abstract: Methods of using compounds to inhibit ocular disease are disclosed herein. Methods are disclosed for inhibiting soluble epoxide hydrolase (sEH) for the treatment of ocular diseases, and in particular, wet age-related macular degeneration (AMD).
    Type: Application
    Filed: April 9, 2021
    Publication date: July 29, 2021
    Inventors: Timothy William Corson, Rania Sulaiman
  • SOLUBLE EPOXIDE HYDROLASE AS A TARGET FOR OCULAR DISEASES
    Publication number: 20190365704
    Abstract: Methods of using compounds to inhibit ocular disease are disclosed herein. Methods are disclosed for inhibiting soluble epoxide hydrolase (sEH) for the treatment of ocular diseases, and in particular, wet age-related macular degeneration (AMD).
    Type: Application
    Filed: August 12, 2019
    Publication date: December 5, 2019
    Inventors: Timothy William Corson, Rania Sulaiman
  • COMPOSITION FOR BLOCKING ANGIOGENESIS
    Publication number: 20180353464
    Abstract: Compositions including the combination of cremastranone analogs and anti-angiogenic agents and the use of the compositions for targeting ocular angiogenesis such as seen in neovascular eye diseases are disclosed.
    Type: Application
    Filed: November 18, 2016
    Publication date: December 13, 2018
    Inventors: Timothy William Corson, Rania Sulaiman
  • SOLUBLE EPOXIDE HYDROLASE AS A TARGET FOR OCULAR NEOVASCULARIZATION
    Publication number: 20180228764
    Abstract: Methods of using compounds that inhibit soluble epoxide hydrolase (sEH) for the treatment of ocular diseases, and in particular, of wet age-related macular degeneration (AMD), are disclosed herein.
    Type: Application
    Filed: February 6, 2018
    Publication date: August 16, 2018
    Inventors: Timothy William Corson, Rania Sulaiman